TLR4 and inflammation: Some non-immunogenic nucleotides with high-affinity HMGB binding may function as suppressing agents for HMGB-mediated inflammation disease by blocking TLR4 activation and macrophage cytokine release (Yang et al., 2010; Yanai et al., 2011).